News
3h
Investor's Business Daily on MSNSynopsys Joins Elite List Of Stocks With 95-Plus Composite RatingThe revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength. The top-performing stocks tend to have a 95 or better grade as they ...
Reality: D-SNPs are designed to be affordable for those eligible for both Medicare and Medicaid. In fact, many D-SNPs have low or even no premiums, and they often include reduced out-of-pocket ...
20d
Zacks Investment Research on MSNSynopsys, Inc. (SNPS) is Attracting Investor Attention: Here is What You Should KnowSynopsys (SNPS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...
14d
Zacks.com on MSNSynopsys (SNPS) Moves 3.6% Higher: Will This Strength Last?Synopsys (SNPS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
In the preceding three months, 8 analysts have released ratings for Synopsys SNPS +0.81% Get Free Report , presenting a wide array of perspectives from bullish to bearish. The table below offers a ...
Chip design software provider Synopsys said it received conditional approval from Chinese regulators for its $35 billion ...
This approach was applied to 524 non-coding SNPs found in the Human Gene Mutation Database, which records the results of human disease association studies. The variants mapped to 350 UTRs, and 206 ...
Another notable valuation metric for SNPS is its P/B ratio of 7.84. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total ...
The number of I-SNPs operating in the US grew from 35 in 2006 to 174 in 2021. Also during that span, the share of long-stay nursing home residents in I-SNPs jumped from 2.2% to 8.8% of all long ...
The usability of SNPs portend a robust market for instrumentation, reagents, software, and services. SNP analysis revenues are estimated to exceed $625 million in 2007 and grow to over $2.2 ...
SNPS currently has a forward P/E ratio of 32.48, while CDNS has a forward P/E of 36.56. We also note that SNPS has a PEG ratio of 2.01. This popular metric is similar to the widely-known P/E ratio ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results